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ABSTRACT
Objective: Trillium govanianum is used in several traditional containing steroids and sex hormones for the management of inflammation, menstrual 
disorders, sex-related disorders, and antiseptic. The present study was aimed to investigate the antifertility potential of hydroalcoholic rhizome 
extract of T. govanianum and to explore the possible mechanism of action.
Methods: Anti-implantation activity of T. govanianum rhizome extract (125 and 250 mg/kg; p.o.) was performed in female Wistar rats with proven 
fertility, and its estrogenic/antiestrogenic effect was evaluated in ovariectomized females. 17-α-ethinylestradiol (1 μg/rat/day; s.c.) or plant extract 
was administered for 11 days after which animals were sacrificed. Percentage inhibition of implantation sites, serum estrogen levels, changes in body 
and uterus weight, and morphological alterations in the uterus and ovaries were evaluated.
Results: T. govanianum treatment resulted in increased uterus weight and induced dose-dependent anti-implantation effect, with 100% implantation 
inhibition at 250 mg/kg dose. Anti-implantation effects of T. govanianum were associated with endometrial thickening and significantly elevated 
serum estrogen levels. Moreover, estrogenic/antiestrogenic studies revealed that T. govanianum possessed strong estrogenic effect; however, the 
effect was saturable.
Conclusion: T. govanianum possesses antifertility activity which can be attributed to its strong estrogenic potential and uterine thickening. Moreover, 
it could find a clinical application as a safer and efficacious birth control herbal remedy.
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INTRODUCTION
Currently available oral contraceptives are associated with several side 
effects such as hormonal imbalance, weight gain, hypertension, and 
increased risk of cancer [1], besides being expensive and not completely 
reliable, thus limiting their use. There is a growing need for alternative 
antifertility strategies which are safer, cost-effective, self-administrable, 
and effective. Plant-based antifertility drugs may be looked on as a 
potential antifertility agent for controlling global population, especially 
in the developing and underdeveloped nations [2].
Trillium govanianum is an important medicinal herb found at an 
altitude of 2400–3500 m in the Himalayan regions. Rhizomes of 
T. govanianum are a rich source of steroids, such as trillarin, which 
on hydrolysis yield diosgenin, a corticosteroid hormone used in 
the preparation of steroidal medicines and sex hormones, such as 
testosterone, glucocorticoids, and progesterone besides being useful 
in rheumatism and regulation of menstrual flow [3,4]. T. govanianum 
is used in several traditional and folk medicines containing steroids 
and sex hormones and for the treatment of ailments such as 
boils, dysentery, inflammation, menstrual disorders, sex-related 
disorders, wound healing, and as an antiseptic [5-7]. The antioxidant, 
analgesic, anti-inflammatory, anticancer, and antifungal potential of 
T. govanianum has been experimentally validated [4,5,8-10]; however, 
the scientific evidence to justify its antifertility potential is lacking. 
Therefore, the present study was aimed to investigate the antifertility 
potential of T. govanianum and to elucidate the possible mechanism.
METHODS
Animals
Wistar rats (200–250 g) were maintained under standard conditions 
with 21±2°C temperature, 60±1% humidity, and 12 h light/dark cycle. 
Animal was fed standard rat pellets and had free access to water. 
Experimental procedures were performed after approval from the 
Institutional Animal Ethical Committee, as per the guidelines of the 
CPCSEA, India.
Anti-implantation activity
Anti-implantation studies were performed in the animals with proven 
fertility in accordance with the procedure described by Taprial 
et  al. (2013). These female animals were divided into three groups 
(n=4–6): Group-1: Control (received 0.3% carboxymethylcellulose as 
vehicle) and Group-2 and Group-3 received 125 and 250 mg/kg TGE, 
respectively (suspended in vehicle). All the treatments were given 
orally (once daily) for 11 days. On the 12th day, animals were weighed 
and sacrificed, and the uterus was harvested, weighed, and examined 
© 2018 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2018.v11i11.27420
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Plant collection and extraction procedure
T. govanianum plant was authenticated by Dr. Jagdish Singh, Himalayan 
Forest Research Institute, Indian Council of Forestry Research 
and Education, Ministry of Environment and Forests,  Governmnet of 
India.  Rhizomes  of  T.  govanianum  were  collected  from  Chamba  region 
(altitude:  3500  m)  of  Himachal  Pradesh,  India,  in  August  2014, 
hydroalcoholic  (30:70;  water:  methanol)  extract  (TGE) was 
prepared  [4],  and  preliminary  phytochemical  screening  was 
performed [11].
330
Asian J Pharm Clin Res, Vol 11, Issue 11, 2018, 329-332
 Sharma et al. 
for implantation sites. Ovaries and uterus were fixed in 4% formalin 
for histopathological examination. Serum was extracted and used for 
estrogen evaluation [12].
Estrogenic/antiestrogenic study
Estrogenic/antiestrogenic effect of plant extract was evaluated in the 
ovariectomized female Wistar rats, as per the method described by 
Taprial et al. [12]. Animals were divided into six groups (n=5). Group-1: 
Control (received vehicle); Group-2 received 17-α-ethinylestradiol (EE; 
1 μg/rat/day; S.C.); Group-3 and Group-4 received 125 and 250 mg/ kg 
TGE, respectively (suspended in vehicle; orally); and Group-5 and 
Group-6 received 125 and 250 mg/kg TGE, respectively (suspended in 
vehicle, orally) along with EE (1 μg/rat/day). All the treatments were 
continued for 11 days. Animals were sacrificed on day 12, body weight 
changes were observed, serum was extracted, and estrogen levels were 
determined [12].
Statistical analysis
Results are depicted as mean±standard deviation. Statistical significance 
was determined using one-way ANOVA followed by Dunnett’s multiple 
comparison test, using GraphPad prism 5 software. All the results were 
compared to control, and the statistical significance was determined at 
*p<0.05, **p<0.01, and ***p<0.001.
RESULTS
Phytochemical screening
Phytochemical screening of the TGE revealed the presence of alkaloids, 
glycosides, flavonoids, tannins, steroids, amino acids, lignin, and inulin 
in the extract. Volatile oil, aleurone grains, fats, and fixed oils were not 
present in the plant extract.
Anti-implantation activity
Results of anti-implantation effect of TGE are depicted in Table 1. 
Control animals demonstrated intact fertility and were observed to 
have 7.8±0.84 implantation sites. A number of implantation sites in 
TGE-treated animals were significantly (p<0.001) reduced in dose-
dependent manner. We observed 82.05% and 100% inhibition of 
implantation at 125 and 250 mg/kg dose, respectively. Further, TGE 
treatment significantly elevates serum estrogen levels, 106.72 and 
216 pg/ml at 125 mg/kg and 250 mg/kg extract treatment, respectively, 
when compared to control (100.84 pg/ml). TGE treatment resulted in 
a significant (p<0.001) increase in uterus weight when compared to 
control animals. These results suggest that TGE possesses strong anti-
implantation effect and may elevate serum estrogen levels.
HISTOPATHOLOGY RESULTS
Results of the histopathological examination of the uterus and 
ovary of the experimental animals are depicted in Fig. 1. Our results 
demonstrated a dose-dependent thickening of uterine endometrium 
wall when compared to control, which might have contributed in the 
anti-implantaion effect of TGE. The ovaries appeared healthy and 
showed morphological resemblance with control animals;, however, a 
slight thickening in the ovarian walls was observed in animals treated 
with 250 mg/kg TGE.
Estrogenic/antiestrogenic study
Estrogen levels were found to be significantly (p<0.001) higher in 
animals treated with 1 μg EE when compared to control. Treating 
animals with TGE resulted in a significant (p<0.001) increase in 
serum estrogen level, which was observed to be 446.21 pg/ml and 
436.2 pg/ml at 125 and 250 mg/kg dose, respectively (Table 1). We 
observed significantly (p<0.001) higher estrogen levels in animals 
treated with plant extract and EE; however, there was a significant 
difference between the extract treatment groups and EE group. These 
results suggest that TGE is having strong estrogenic effect, which 
appears to be saturable. Moreover, EE, TGE, and TGE+EE treatments 
significantly (p<0.01) increased the body weight and uterus weight of 
animals (Table 1) when compared to control.
DISCUSSION
The traditional use of herbal remedies has high fascination but lack 
scientific justifications, and very few remedies have been explored for 
their efficacy and mechanism of action [13]. Rhizomes of T. govanianum 
are a rich source of steroids and have been used traditionally during 
menstrual disorders and in the treatment of sex-related disorders 
in several folk medicines [5-7]. In the present study, we evaluated 
the antifertility effect of TGE through anti-implantation studies and 
investigated the potential mechanism. TGE treatment demonstrated a 
strong dose-dependent anti-implantation effect that could be attributed 
to its potential to induce endometrial thickening and estrogenic 
effect. Previously, anti-implantation effects of plant extract have 
been attributed to endometrial thickening and changes in estrogenic 
profile during extract treatment [12]. To investigate this possibility, we 
evaluated its estrogenic/antiestrogenic potential in the ovariectomized 
rats. Our results demonstrated a strong estrogenic effect, and the levels 
of serum estrogens were found to be significantly (p<0.001) higher 
than control animals. Interestingly, we did not observe any significant 
difference in the serum estrogen levels when control+EE animals were 
compared with the 125 mg/kg extract+EE and 250 mg/kg extract+EE-
treated animals. To add further, there was an insignificant difference in 
the serum estrogen levels between different doses of extract treatment, 
in both EE-treated and non-treated groups. These results suggest that 
the estrogenic effect of T. govanianum is a saturable process. This 
may be explained on the basis of steroidal phytochemical, trillian, 
present in this plant [4], which can be converted into bioactive steroid 
diosgenin within the body through hydrolysis, which is a saturable 
process. Moreover, this gives an added advantage for the antifertility 
use of this plant in the clinical settings, as the estrogen levels will 
not increase uncontrolled and therefore side effects of antifertility 
agents such as hormonal imbalance could be eliminated. Our results 
are in agreement with the previous reports where several plant 
extracts, namely Afrormosia laxiflora, Pterocarpus erinaceus, Michelia 
champaca, and Striga orobanchioides, have been reported to possess 
Table 1: Anti-implantation and estrogenic/antiestrogenic effect of the hydroalcoholic rhizome extract of T. govanianum
Treatment Anti-implantation study Estrogenic/antiestrogenic effect
















Serum estrogen  
(pg/ml)
Control 5.48±0.81 7.8±0.84 0 100.84±5.21 32.3±5.81 0.36±0.03 24.3±1.31 48.255±3.58
EE - - - - - 3.86±1.22*** 62.56±6.45*** 2251.38±117.25***
TG-125 3.64±0.3 1.4±0.55*** 82.05*** 106.72±6.11 89.51±8.11*** 2.24±1.32** 56.25±5.34*** 446.21±29.42***
TG-250 4.09±0.61 0*** 100*** 216±15.81*** 112.21±12.11*** 4.33±1.16*** 72.66±7.39*** 436.2±21.27***
TG-125+EE - - - - - 4.46±0.51*** 71.46±5.21*** 2922.11±110.15***
TG-250+EE - - - - - 4.01±1.05*** 96.32±8.34*** 2138.39±131.1***
EE: 17-α-ethinylestradiol (administered through subcutaneous injection at the dose of 1 μg/rat/day); TG-125: Hydroalcoholic rhizome extract of T. govanianum  
(administered orally at the dose of 125 mg/kg); TG-250: Hydroalcoholic rhizome extract of T. govanianum (administered orally at the dose of 220 mg/kg). *Treatment 
versus control. *p<0.05, **p<0.01, and ***p<0.001. 
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estrogenic activity  [12,14], which has been associated with antifertility 
properties [12].
Moreover, changes in estrogen and progesterone balance may lead to 
abortion or termination of pregnancy, which is the mechanism used by 
the clinical synthetic steroidal oral contraceptives [15-17]. Rhizomes of 
T. govanianum are a rich source of steroids, which can be hydrolyzed 
to diosgenin [4], which is used as a raw material for manufacturing 
synthetic steroidal contraceptives [15]. Therefore, orally administering 
TGE might have disturbed estrogen-progesterone balance to produced 
antifertility effect.
CONCLUSION
Oral administration of TGE to female Wistar rats induces dose-
dependent anti-implantation activity, which can be attributed to its 
strong estrogenic potential and uterine thickening. Estrogenic effect 
in ovariectomized rats was observed to be a saturable process and 
thereby could be free from the side effects of currently used steroidal 
contraceptives. T. govanianum could find a clinical application as a safer 
and efficient herbal birth control strategy.
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